Our work

Medicine in Need (MEND) is a pharmaceutical technology platform corporation organized as a 501c3 corporation, a US non-profit entity.

MEND's mission is to apply advanced delivery technologies to vaccine and drug candidates to promote new, improved, and sustainable products for diseases of poverty, primarily tuberculosis, HIV/AIDS and Malaria.

We are engaged in developing vaccine and drug products for infectious diseases based on our core proprietary delivery technology platform (drying methods of biological micro-organisms, cells, or cellular components).

We also fosters an international consortium of technology and vaccine/drug developers so as to match – and resource through preclinical, clinical, and business services – advanced delivery technologies with preclinical and clinical product needs to promote more sustainable products.

We are building and operating a major international communications program around delivery technologies and therapies and/or vaccines for neglected diseases of poverty that facilitates dialog between developed and developing countries.

MEND's biotechnology team and transcontinental R&D infrastructure is based in the US, Europe and Africa support multiple key translational projects through early human clinical development (Phase I & II).